JPWO2021084665A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021084665A5
JPWO2021084665A5 JP2021553970A JP2021553970A JPWO2021084665A5 JP WO2021084665 A5 JPWO2021084665 A5 JP WO2021084665A5 JP 2021553970 A JP2021553970 A JP 2021553970A JP 2021553970 A JP2021553970 A JP 2021553970A JP WO2021084665 A5 JPWO2021084665 A5 JP WO2021084665A5
Authority
JP
Japan
Prior art keywords
pdgf
skin
production enhancer
extract
aging
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021553970A
Other languages
Japanese (ja)
Other versions
JPWO2021084665A1 (en
JP7433337B2 (en
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2019/042689 external-priority patent/WO2021084665A1/en
Publication of JPWO2021084665A1 publication Critical patent/JPWO2021084665A1/ja
Publication of JPWO2021084665A5 publication Critical patent/JPWO2021084665A5/ja
Priority to JP2024016646A priority Critical patent/JP2024036562A/en
Application granted granted Critical
Publication of JP7433337B2 publication Critical patent/JP7433337B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Claims (3)

ハイビスカス抽出物、ワサビ抽出物、カミツレ抽出物、及びL-テアニンの少なくともいずれかを有効成分として含んでなる血小板由来成長因子-BB（PDGF-BB）産生亢進剤。 A platelet-derived growth factor-BB (PDGF-BB) production enhancer comprising at least one of hibiscus extract, wasabi extract, chamomile extract and L-theanine as an active ingredient. 請求項１に記載のPDGF-BB産生亢進剤を含んでなる、幹細胞安定化剤。 A stem cell stabilizing agent comprising the PDGF-BB production enhancer according to claim 1 . 請求項１に記載のPDGF-BB産生亢進剤を含んでなる皮膚抗老化剤であって、皮膚における幹細胞を安定化することにより皮膚の老化を抑制する、皮膚抗老化剤。 A skin anti-aging agent comprising the PDGF-BB production enhancer according to claim 1, which suppresses skin aging by stabilizing stem cells in the skin.
JP2021553970A 2019-10-30 2019-10-30 Platelet-derived growth factor (PDGF) - BB production enhancer, stem cell stabilizer containing the same, and skin anti-aging agent containing the same Active JP7433337B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024016646A JP2024036562A (en) 2019-10-30 2024-02-06 Platelet-derived growth factor (pdgf)-bb production promoter, stem cell stabilizer containing this, and skin anti-aging agent containing these

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP2019/042689 WO2021084665A1 (en) 2019-10-30 2019-10-30 Platelet-derived growth factor (pdgf)-bb production promoter, stem cell stabilizer containing this, and skin anti-aging agent containing these

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024016646A Division JP2024036562A (en) 2019-10-30 2024-02-06 Platelet-derived growth factor (pdgf)-bb production promoter, stem cell stabilizer containing this, and skin anti-aging agent containing these

Publications (3)

Publication Number Publication Date
JPWO2021084665A1 JPWO2021084665A1 (en) 2021-05-06
JPWO2021084665A5 true JPWO2021084665A5 (en) 2022-09-07
JP7433337B2 JP7433337B2 (en) 2024-02-19

Family

ID=75715893

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021553970A Active JP7433337B2 (en) 2019-10-30 2019-10-30 Platelet-derived growth factor (PDGF) - BB production enhancer, stem cell stabilizer containing the same, and skin anti-aging agent containing the same
JP2024016646A Pending JP2024036562A (en) 2019-10-30 2024-02-06 Platelet-derived growth factor (pdgf)-bb production promoter, stem cell stabilizer containing this, and skin anti-aging agent containing these

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024016646A Pending JP2024036562A (en) 2019-10-30 2024-02-06 Platelet-derived growth factor (pdgf)-bb production promoter, stem cell stabilizer containing this, and skin anti-aging agent containing these

Country Status (2)

Country Link
JP (2) JP7433337B2 (en)
WO (1) WO2021084665A1 (en)

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05163135A (en) * 1991-12-16 1993-06-29 Suntory Ltd Beautifying cosmetic composition
JP3748941B2 (en) * 1996-05-01 2006-02-22 株式会社ナリス化粧品 Anti-aging cosmetic
JPH11137212A (en) * 1997-11-14 1999-05-25 Sogo Pharmaceut Co Ltd Beauty culture composition
JP2004131500A (en) * 2002-09-19 2004-04-30 Fancl Corp Skin aging inhibitor or improver
JP2005314289A (en) * 2004-04-28 2005-11-10 Kinjirushi Kk Ultraviolet hazard inhibitor
JP2006241005A (en) * 2005-03-01 2006-09-14 Kinjirushi Kk Skin aging-preventing agent and cosmetic
FR2902340B1 (en) * 2006-06-16 2011-03-18 Seri Nomura COSMETIC COMPOSITION FOR TOPICAL USE COMPRISING WASABI
KR20090064743A (en) * 2007-12-17 2009-06-22 (주)아모레퍼시픽 Composition of the skin external application or the food for accelerating proline recycling containing theanine
EP2617835A4 (en) * 2010-09-17 2014-03-19 Shiseido Co Ltd Skin activation by means of pdgf-bb activity enhancement
JP5496951B2 (en) * 2011-06-15 2014-05-21 株式会社 資生堂 Platelet-derived growth factor (PDGF) -BB production enhancer and stem cell stabilizer containing the same
JP6485995B2 (en) * 2013-05-10 2019-03-20 丸善製薬株式会社 Endothelin-1 mRNA expression increase inhibitor, stem cell growth factor mRNA expression increase inhibitor, basic fibroblast growth factor mRNA expression increase inhibitor, and proopiomelanocortin mRNA expression increase inhibitor
JP2015117221A (en) * 2013-12-20 2015-06-25 一丸ファルコス株式会社 Stem cell activation agent
JP2015155394A (en) * 2014-02-21 2015-08-27 佐藤製薬株式会社 photoaging inhibitor
JP6138317B2 (en) * 2016-05-10 2017-05-31 株式会社ノエビア Topical skin preparation
JP6928429B2 (en) * 2016-08-05 2021-09-01 共栄化学工業株式会社 Topical skin agent
JPWO2019017355A1 (en) * 2017-07-18 2020-05-28 株式会社 資生堂 Mesenchymal stem cell attractant
CN109762782B (en) 2019-02-27 2022-05-03 嘉文丽（福建）化妆品有限公司 Culture medium for promoting growth of mesenchymal stem cells and preparation method thereof

Similar Documents

Publication Publication Date Title
WO2016037154A8 (en) Recombinant hiv-1 envelope proteins and their use
JP2017528885A5 (en)
JP2015520726A5 (en)
NO20080564L (en) Antitumoral bioconjugates of hyaluronic acid or its derivatives obtained by indirect chemical conjugation and their use in the pharmaceutical field
EA201591276A1 (en) PHARMACEUTICAL COMPOSITION WITH IMPROVED Bioavailability
JP2008290071A5 (en)
CA3010829A1 (en) Gel compositions for transdermal delivery to maximize drug concentrations in the stratum corneum and serum and methods of use thereof
CL2020002252A1 (en) Ophthalmic formulation.
EP3595059A4 (en) Positive electrode active material, and cell
WO2016085127A3 (en) Stable peptide-conjugated ascorbic acid derivative, method for preparing same, and cosmetic composition containing same
MY173573A (en) Pyridin-4-yl derivatives
WO2018098282A3 (en) Cyclic cell penetrating peptides comprising beta-hairpin motifs and methods of making and using thereof
WO2012052479A3 (en) Brimonidine gel compositions and methods of use
MX2021003002A (en) Composition for treating fibrotic diseases, comprising benzhydryl thioacetamide compound as active ingredient.
FI3248597T3 (en) Therapeutic agent for sensorineural hearing loss
WO2017220042A3 (en) Amrinone pharmaceutical composition and application thereof in hypertension treatment
WO2018106108A8 (en) Topical pharmaceutical composition containing phenytoin and a (co -)an algesic for the treatment of chronic pain
MX367321B (en) Skin care composition and method thereof.
MX2019000031A (en) Methods for the preparation of a levothyroxine solution.
CO6592109A2 (en) New crystalline form of a cyclopropylbenzamide derivative
JPWO2021084665A5 (en)
WO2016205397A3 (en) Target-specific delivery of therapeutic agents
JP2015535241A5 (en)
JP2016126935A5 (en)
WO2015040497A3 (en) Methods for nuclear reprogramming of cells